$4450
$3560
The embolization devices market size is projected to reach US$ 5.89 billion by 2031 from US$ 3.07 billion in 2024. The market is expected to register a CAGR of 9.9% during 2025-2031. Transforming embolization through clinical innovation is likely to bring new trends in the embolization devices market in the coming years.
Embolization Devices Market Analysis
The factors driving the embolization devices market include the rising prevalence of clinical conditions and burgeoning demand for minimally invasive techniques. Additionally, increasing awareness about various conditions and the development of new technologies are expected to contribute to market growth in the near future. Moreover, new product developments and marketing approvals are expected to create ample opportunities in the coming years.
Embolization Devices Market Overview
North America is projected to dominate the embolization devices market with the largest share during the forecast period. Further, Asia Pacific is expected to register a significant CAGR owing to the increasing prevalence of cancer and other clinical conditions, leading to a higher demand for interventional procedures. Technological advancements also played a crucial role in the market growth. Innovations in embolization devices, such as drug-eluting beads, microcatheters, and novel coil designs, have enhanced the efficacy and safety profiles of embolization procedures. These advancements not only improve clinical outcomes but also reduce procedure times and post-operative complications, making them more attractive among healthcare providers and patients. The shift toward minimally invasive surgical techniques is another significant factor bolstering the popularity of the embolization technique. Minimally invasive procedures aid in reduced hospital stays, quicker recovery times, and lower risk of complications compared to open surgeries. As healthcare providers and patients increasingly recognize these advantages, the demand for embolization procedures is expected to rise.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Embolization Devices Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Embolization Devices Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Embolization Devices Market Drivers and Opportunities
Rising Prevalence of Clinical Conditions Favors Market Growth
Vascular diseases, including peripheral artery disease (PAD), aneurysms, and arteriovenous malformations (AVMs), are becoming more prevalent globally. These conditions have become particularly common among geriatric populations and individuals exposed to lifestyle-related risk factors. Peripheral vascular disease (PVD) consists of PAD and venous disease. According to the article "Income-Related Peripheral Artery Disease Treatment," published in the National Library of Medicine in 2022, more than 200 million people worldwide suffer from PAD, and ~10% of the affected people in Western Europe and North America were aged 50 years and above. The prevalence of PVD ranges from 3% in patients aged >55 years and 11% in patients aged >65 years to 20% in patients aged >75.
The cases of neurovascular conditions such as strokes and brain aneurysms are also on the rise across the world. As per the Brain Aneurysm Foundation estimates, 6.8 million people in the US have an unruptured brain aneurysm. Each year, nearly 30,000 Americans suffer a brain aneurysm rupture, often requiring immediate intervention through embolization techniques. Almost 500,000 people die worldwide due to brain aneurysms each year. Brain aneurysms are most prevalent in people from the age group of 35–60, and most aneurysms develop after the age of 40. Additionally, ruptured brain aneurysms account for 3–5% of all new strokes.
As per the World Health Organization (WHO), postpartum hemorrhage is the foremost cause of maternal mortality globally. Nearly 14 million women suffer from this condition each year, resulting in approximately 70,000 post-partem deaths worldwide. Additionally, as per the Institute for Functional Medicine, the prevalence of uterine fibroids has increased by 78.82% in the past 30 decades, growing from 126.41 million to 226.05 million in terms of number of cases. These clinical conditions can be effectively treated using embolization devices, which are designed to block abnormal or excessive blood flow within blood vessels. The technique is preferred due to its minimally invasive nature. Embolization involves the deliberate occlusion of blood vessels to treat conditions such as aneurysms, postpartum hemorrhage, uterine fibroids, and certain types of tumors. It is used to control severe bleeding after childbirth when conventional methods are ineffective, as well as block the blood supply to fibroids, causing them to shrink and symptoms to improve.
New Product Developments and Marketing Approvals Create Ample Opportunities for Market Growth
Small and big companies operating in the embolization devices market are increasingly adopting strategies such as geographic expansions, new product developments, and technological advancements to boost their revenues. A few of the noteworthy product developments and approvals in the embolization devices market, which are expected to drive its growth in the coming years, are mentioned below.
- In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. This innovative, proprietary medical device has been designed for the minimally invasive interventional treatment of peripheral arterial embolism. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, and the endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system. With the regulatory approval for the use in these applications, the system has received international recognition for its safety and efficacy.
- In October 2023, Sirtex Medical launched the Lava Liquid Embolic System (LES), approved for the treatment of peripheral vascular hemorrhage. According to the company, Lava offers customizable volume and viscosity options to enable precise and controlled occlusion of target vessels. Available in 2-mL and 6-mL configurations, the system is specifically optimized for use in the peripheral vasculature. Its range of viscosities allows for effective distal embolization, reaching small and otherwise inaccessible vessels where other embolic agents may be less effective.
- In April 2022, Boston Scientific Corporation received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil designed to block or reduce the blood flow rate in the peripheral vasculature. As the newest addition to Boston Scientific's interventional oncology portfolio, the coil was designed for use in various embolization procedures, necessarily minimally invasive treatments intended to block one or more blood vessels to obstruct or reduce blood flow. The EMBOLD Fibered Detachable Coil features a single platform consisting of three coils, making it simpler for physicians to address various patient needs and anatomies.
- In March 2022, Artio Medical, Inc. received US FDA clearance for its Solus Gold Embolization Device, a next-generation solution for peripheral vascular occlusion. Designed to reduce or block blood flow within the peripheral vasculature, the device comes with a delivery system that combines flexibility with pushability, allowing physicians to navigate complex anatomies with ease.
Therefore, new product developments and marketing approvals are anticipated to create lucrative growth opportunities in the embolization devices market.
Embolization Devices Market Report Segmentation Analysis
Key segments that form the foundation of the embolization devices market analysis are product type, application, and end user.
- Based on product type, the embolization devices market is segmented into embolization coils, plugs, beads, glues, and others. The embolization coils segment held the largest market share in 2024 and is expected to register the highest CAGR during 2024–2031.
- By application, the embolization devices market is segmented into neurology, peripheral vascular disease, oncology, urology, and others. The neurology segment held the largest share of the market in 2024, and it is expected to register the highest CAGR in the market during 2024–2031.
- In terms of end user, the embolization devices market is segmented into hospitals, ambulatory centers, and others. The hospitals segment dominated the market in 2024 and is anticipated to register the highest CAGR during 2024–2031.
Embolization Devices Market Share Analysis by Geography
The geographical scope of the embolization devices market report is mainly divided into five regions: North America, Asia Pacific, Europe, and Middle East & Africa, and South & Central America. North America held a significant share of the market in 2024. The embolization devices market in North America is driven by the region’s advanced healthcare infrastructure, increasing prevalence of vascular diseases, and growing adoption of minimally invasive procedures. Technological advancements have led to a significant enhancement in the precision and safety of embolization techniques, making them a preferred choice for treating conditions such as aneurysms, arteriovenous malformations, and tumors. The high patient awareness about various medical conditions and treatment options, strong healthcare reimbursement systems, and the presence of leading medical device companies contribute to the market’s maturity in North America. Additionally, public health campaigns play a crucial role in promoting embolization procedures. Ongoing research and clinical trials are further expanding the scope of embolization technologies, with a particular focus on biodegradable and drug-eluting embolic agents. While the US leads in terms of adoption and innovation, Canada and Mexico are progressively increasing their market participation through supportive policies and infrastructure development. However, disparities in healthcare access across rural and urban settings remain a challenge. As a result, North American countries continue to attract significant investments, along with prompting collaborations among hospitals, research institutes, and device manufacturers, ensuring sustained development and innovation in embolization technologies.
Embolization Devices Market Report Scope
Embolization Devices Market News and Recent Developments
The embolization devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- Stryker has entered into a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. for US$ 80 per share in cash, representing a total fully diluted equity value of approximately US$ 4.9 billion. Inari will help Stryker gain a leading position in the fast-growing segment of venous thromboembolism (VTE). Inari’s innovative product portfolio complements Stryker’s Neurovascular business and includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. (Source: Stryker, Company Website, 2025)
- Boston Scientific Corporation has entered into a definitive agreement to acquire Intera Oncology Inc. Intera Oncology is a privately held medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine (a chemotherapy drug), both of which are approved by the US Food and Drug Administration. The Intera 3000 pump is used to administer hepatic artery infusion (HAI) therapy to treat tumors in the liver primarily caused by metastatic colorectal cancer. (Source: Boston Scientific Corporation, Company Website, 2024)
- CERENOVUS Inc., a part of Johnson & Johnson MedTech, launched TRUFILL n-BCA Liquid Embolic System Procedural Set. With the latest addition, the CERENOVUS hemorrhagic stroke portfolio now offers TRUFILL n-BCA Liquid Embolic System as a new procedural set that includes two configurations and the accessories needed to undertake preparation and deliver n-BCA Liquid Embolic System in one sterilized set, creating streamlined procedure preparation. (Source: CERENOVUS Inc, Company Website, 2024)
Embolization Devices Market Report Coverage and Deliverables
The “Embolization Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Embolization devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Embolization devices market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Embolization devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the embolization devices market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The embolization devices market is estimated to register a CAGR of 9.9% during the forecast period.
The embolization devices market is estimated to reach a value of US$ 5.89 billion by 2031.
Medtronic Plc,; Cook Medical Holdings LLC,; Stryker Corp,; Boston Scientific Corp,; Terumo Corp,; Johnson & Johnson,; Abbott Laboratories,; NeuroSafe Medical Co. Ltd,; Wallaby Medical,; Sirtex Medical Ltd,; GEM srl,; Balt,; Lepu Medical Technology Beijing Co Ltd,; INVAMED,; Meril Life Sciences Pvt Ltd,; Merit Medical Systems Inc,; and Lifetech Scientific Corp are among the key players operating in the embolization devices market.
North America dominated the market in 2024.
The rising prevalence of clinical conditions and burgeoning demand for minimally invasive techniques are the most influential factors responsible for the market growth.
The List of Companies - Embolization Devices Market
- Medtronic Plc
- Cook Medical Holdings LLC
- Stryker Corp
- Boston Scientific Corp
- Terumo Corp
- Johnson & Johnson
- Abbott Laboratories
- NeuroSafe Medical Co. Ltd
- Wallaby Medical
- Sirtex Medical Ltd
- GEM srl
- Balt
- Lepu Medical Technology Beijing Co Ltd
- INVAMED
- Meril Life Sciences Pvt Ltd
- Merit Medical Systems Inc
- Lifetech Scientific Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Embolization Devices Market
Jun 2025
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Jun 2025
Pediatric Cardiology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Transcatheter Heart Valves, Occlusion Devices, Catheters, Stents, Introducer Sheaths, and Others), Disease Indication (Congenital Heart Disease, Acquired Heart Disease, Arrhythmias, Cardiomyopathies, and Others), Surgical Procedure (Interventional Procedures, Heart Rhythm Management Procedures, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2025
Pharmaceutical Membrane Filters Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Microfiltration, Ultrafiltration, Reverse Osmosis and Nanofiltration), Design (Hollow Fiber, Spiral Wound, Tubular System and Plate and Frame), Material (Polyethersulfone (PES), Polysulfone (PS), Cellulose-Based Membranes, Polytetrafluoroethylene (PTFE), Polyvinyl Chloride (PVC), Polyacrylonitrile (PAN) and Others), End User (Pharmaceutical and Biotech Industries and CROs and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
Jun 2025
ECG Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG and Stress ECG), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2025
Surgical Laser Fiber Units Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (CO2 Laser, Diode Laser, Erbium Laser, Nd:YAG Laser, Holmium Laser, Alexandrite Laser, and Others), Material (Silica-Based Fibers, Quartz Fibers, Polymer-Based Fibers, Multimode Fibers, and Others), Power (Low-Power Lasers, Medium-Power Lasers, and High-Power Lasers), Application (Urology, Dermatology, Gynecology, Cardiology, Neurology, Ophthalmology, Respiratory, Dentistry and Others), Wavelength (9,301 nm and above, 2,941–9,300 nm, and 1,441–2,940 nm, 821–1,440 nm, 710–820 nm, and below 710 nm), End User (Hospitals, Specialty Clinics, Physician Office, and Others), and Geography
Jun 2025
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography
Jun 2025
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography
Jun 2025
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)